| Hang Seng Index | 23.860 HKD | +0.300 | +1.273% | 425.56M | 10.10B | 23.543 (+1.346%) HKD as at 2025/05/28 | | |
| Hang Seng China Enterprises | 88.140 HKD | +1.240 | +1.427% | 70.52M | 6.18B | 87.163 (+1.121%) HKD as at 2025/05/27 | | |
| Hang Seng TECH Index | 5.195 HKD | +0.130 | +2.567% | 735.33M | 3.78B | 5.080 (+2.258%) HKD as at 2025/05/27 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 5.115 HKD | +0.243 | +4.988% | 276.93M | 1.39B | 4.917 (+4.033%) HKD as at 2025/05/27 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.762 HKD | -0.094 | -5.065% | 643.81M | 1.16B | 1.845 (-4.488%) HKD as at 2025/05/27 | | |
| Hang Seng TECH Index | 6.730 HKD | +0.165 | +2.513% | 60.55M | 408.09M | 6.571 (+2.420%) HKD as at 2025/05/28 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 2.348 HKD | -0.070 | -2.895% | 155.60M | 369.96M | 2.406 (-2.407%) HKD as at 2025/05/27 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 5.050 HKD | +0.152 | +3.103% | 47.51M | 236.68M | 4.929 (+2.453%) HKD as at 2025/05/27 | | |
| Hang Seng TECH Index | 11.160 HKD | +0.290 | +2.668% | 17.33M | 191.33M | 10.896 (+2.422%) HKD as at 2025/05/27 | | |
| London Gold Fixing Price | 2,375.000 HKD | -24.000 | -1.000% | 70.60K | 166.61M | N/A | | |
| FTSE China A50 | 14.000 HKD | -0.060 | -0.427% | 8.29M | 116.19M | 14.050 (-0.359%) HKD as at 2025/05/27 | | |
| FTSE China A50 | 13.100 HKD | +0.020 | +0.153% | 7.82M | 102.33M | 13.110 (-0.078%) HKD as at 2025/05/27 | | |
| Hang Seng TECH Index | 5.270 HKD | +0.130 | +2.529% | 16.45M | 86.09M | 5.154 (+2.247%) HKD as at 2025/05/27 | | |
| Hang Seng China Enterprises | 10.560 HKD | +0.070 | +0.667% | 5.41M | 56.83M | 10.433 (+1.221%) HKD as at 2025/05/27 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 4.336 HKD | -0.172 | -3.815% | 11.12M | 48.41M | 4.495 (-3.546%) HKD as at 2025/05/27 | | |
| CSI 300 | 43.020 HKD | -0.480 | -1.103% | 1.08M | 46.76M | 43.351 (-0.763%) HKD as at 2025/05/27 | | |
| FTSE China A50 | 12.870 CNY | -0.020 | -0.155% | 2.20M | 28.39M | 12.891 (-0.161%) CNY as at 2025/05/27 | | |
| Solactive China Healthcare Disruption Index | 2.722 HKD | +0.132 | +5.097% | 8.38M | 22.41M | 2.620 (+3.889%) HKD as at 2025/05/27 | | |
| FTSE US Treasury 20+ Years Index | 66.660 HKD | -0.520 | -0.774% | 329.17K | 22.01M | 67.292 (-0.938%) HKD as at 2025/05/27 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 16.690 HKD | -0.310 | -1.824% | 1.32M | 21.71M | 16.843 (-0.908%) HKD as at 2025/05/27 | | |
| CME CF Bitcoin Reference Rate- Asia Pacific Variant | 13.390 HKD | -0.100 | -0.741% | 1.58M | 21.19M | 13.487 (-0.720%) HKD as at 2025/05/28 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 0.661 HKD | -0.025 | -3.644% | 26.74M | 17.73M | 0.684 (-3.377%) HKD as at 2025/05/27 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng China Enterprises | 3.160 HKD | +0.100 | +3.268% | 4.28M | 13.26M | 3.075 (+2.771%) HKD as at 2025/05/27 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 12.500 HKD | +0.670 | +5.664% | 986.70K | 12.06M | 11.825 (+5.713%) HKD as at 2025/05/28 | | |
| CME CF Ether-Dollar Reference Rate - Asia Pacific Variant | 6.600 HKD | +0.245 | +3.855% | 1.73M | 11.44M | 6.342 (+4.063%) HKD as at 2025/05/28 | | |
| FTSE 3-Month US Dollar Eurodeposit Index | 118.000 USD | -0.050 | -0.042% | 87.41K | 10.32M | 117.991 (+0.008%) USD as at 2025/05/27 | | |
| Solactive China Electric Vehicle and Battery Index (net total return) | 86.200 HKD | +0.240 | +0.279% | 106.24K | 9.07M | 87.192 (-1.137%) HKD as at 2025/05/27 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | CSI 300 | 3.508 HKD | +0.028 | +0.805% | 2.50M | 8.79M | 3.523 (-0.420%) HKD as at 2025/05/27 | | |
| Hang Seng High Dividend Yield | 26.420 HKD | +0.100 | +0.380% | 322.81K | 8.50M | 26.291 (+0.492%) HKD as at 2025/05/27 | | |
| CSI Hong Kong Dividend | 35.100 HKD | 0.000 | 0.000% | 242.10K | 8.48M | 35.022 (+0.223%) HKD as at 2025/05/28 | | |